Back to Search
Start Over
First Participant Treated Using NorthStar Medical Radioisotopes Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals' Phase I|IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma
- Source :
- Plus Company Updates. August 29, 2023
- Publication Year :
- 2023
-
Abstract
- BELOIT: NorthStar Medical Radioisotopes, LLC (NorthStar), a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, is pleased to announce that the [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.763273852